Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Intas Pharmaceuticals is a leading vertically integrated global pharmaceutical company based in India, specializing in formulation development, manufacturing, and marketing. The "Third Party Sales" division serves as the company's contract manufacturing and out-licensing arm, providing high-quality generic and biosimilar products to global partners. Intas maintains a robust presence in chronic therapeutic areas including oncology, cardiology, neurology, and nephrology. The company is globally recognized for its biosimilar portfolio, marketed largely through its international subsidiary, Accord Healthcare. With over 15 manufacturing facilities approved by major regulatory agencies like the US FDA and EMA, Intas offers extensive CDMO capabilities across various dosage forms. As one of the largest privately held pharmaceutical firms in India, Intas continues to expand its footprint in highly regulated markets through strategic alliances and a strong R&D pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intas Third Party Sales.